We are live on ! Find out more
BDSX icon

Biodesix

26 hedge funds and large institutions have $10.8M invested in Biodesix in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $10M → $10.8M (+$791K)

0.24% less ownership

Funds ownership: 1.21%0.98% (-0.24%)

35% less funds holding

Funds holding: 4026 (-14)

64% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 14

74% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 19

Holders
26
Holders Change
-14
Holders Change %
-35%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
14
Closed
19
Calls
$121K
Puts
Net Calls
+$121K
Net Calls Change
+$121K
Name Holding Trade Value Shares
Change
Change in
Stake
TAM
1
Telemark Asset Management
Massachusetts
$3.13M -$8 -1 -0%
BC
2
Birchview Capital
Vermont
$2.17M -$15 -2 -0%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.37M -$59.7K -7,764 -4%
PA
4
Perceptive Advisors
New York
$821K
MIM
5
Monashee Investment Management
Massachusetts
$755K -$31 -4 -0%
PCM
6
Perkins Capital Management
Minnesota
$397K -$2.71K -353 -0.7%
SCM
7
Silverarc Capital Management
Massachusetts
$375K -$30.1K -3,911 -7%
GCP
8
GSA Capital Partners
United Kingdom
$365K +$13.6K +1,772 +4%
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$325K +$369 +48 +0.1%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$304K +$20.6K +2,674 +7%
BlackRock
11
BlackRock
New York
$185K -$8 -1 -0%
State Street
12
State Street
Massachusetts
$116K -$8 -1 -0%
OIM
13
Oracle Investment Management
Connecticut
$113K +$115K +15,000 New
Millennium Management
14
Millennium Management
New York
$113K +$115K +14,944 New
SC
15
Shay Capital
New York
$106K +$18.9K +2,455 +21%
CS
16
Cannell & Spears
New York
$77.6K -$8 -1 -0%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$67K +$68.5K +8,901 New
AF
18
Allworth Financial
California
$37.5K -$15 -2 -0%
CIBC Private Wealth Group
19
CIBC Private Wealth Group
Georgia
$11.1K -$8 -1 -0.1%
TRCT
20
Tower Research Capital (TRC)
New York
$4.86K -$6.07K -789 -55%
FFO
21
Fortitude Family Office
Arizona
$1.29K +$1.31K +171 New
Group One Trading
22
Group One Trading
Illinois
$755 +$769 +100 New
Morgan Stanley
23
Morgan Stanley
New York
$574 +$92 +12 +19%
Bank of America
24
Bank of America
North Carolina
$226 -$62 -8 -21%
Barclays
25
Barclays
United Kingdom
$8 -$62 -8 -89%

BDSX Hedge Fund Activity: Q3 2025 in Review

26 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q3 2025, worth a combined $10.8M — up 7.9% from $10M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of BDSX and 5 opened new positions — a net loss of 14 holders — while 14 trimmed existing stakes and 5 added.

The largest buyer was Oracle Investment Management, opening a new position worth an estimated $115K. The largest seller was Wilmington Savings Fund Society, exiting entirely with an estimated $1.72M sold.

  • 26 institutional investors held Biodesix (BDSX) as of Q3 2025, down from 40 in Q2 2025.
  • Funds reported $10.8M of Biodesix stock for Q3 2025, up 7.9% quarter-over-quarter.
  • 5 funds opened new Biodesix positions in Q3 2025 and 19 closed out, a net change of -14 holders.
  • The largest Biodesix buyer in Q3 2025 was Oracle Investment Management, an estimated $115K added.
  • The largest Biodesix seller in Q3 2025 was Wilmington Savings Fund Society, an estimated $1.72M sold.

Based on aggregated 13F filings for Q3 2025.